Related Experiment Video
Updated: Mar 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Enhanced MAPK signaling is essential for CSF3R-induced leukemia
S Rohrabaugh1, M Kesarwani1, Z Kincaid1
1Division of Experimental Hematology and Cancer Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
CSF3R mutations drive chronic neutrophilic leukemia (CNL). Proximal and compound CSF3R mutations induce leukemia by enhancing MAPK signaling, which trametinib can suppress, suggesting MEK1/2 inhibition for CNL treatment.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Mutations in CSF3R (colony-stimulating factor 3 receptor) are implicated in chronic neutrophilic leukemia (CNL).
- Both membrane-proximal and truncation mutations have been associated with CNL onset.
Purpose of the Study:
- To investigate the distinct leukemogenic potential of different CSF3R mutations.
- To elucidate the molecular mechanisms underlying CSF3R-driven leukemogenesis.
- To evaluate the therapeutic efficacy of MEK1/2 inhibition in CNL.
Main Methods:
- Comparative whole-genome expression profiling.
- Biochemical experiments to assess signaling pathways.
- In vivo studies using mouse models of CNL.
- Pharmacological inhibition of MEK1/2 with trametinib.
Main Results:
- Truncation mutations alone were not leukemogenic.
- Proximal and compound CSF3R mutations induced leukemia with distinct latencies (90 and 23 days, respectively).
- Upregulation of Ksr1 and enhanced MAPK signaling were crucial for leukemogenesis.
- Trametinib effectively suppressed leukemia in both proximal and ruxolitinib-resistant compound mutant models.
Conclusions:
- CSF3R proximal and compound mutations drive CNL through a MAPK-dependent pathway.
- MEK1/2 inhibition represents a promising therapeutic strategy for CNL.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Amplifying Signals via Enzymatic Cascade

